PERIMETER MEDICAL IMAGING AI (PINK.CA) Stock Fundamental Analysis
Canada - TSX Venture Exchange - TSX-V:PINK - CA71385D1078 - Common Stock
0.345 CAD
-0.03 (-6.76%)
Overall PINK gets a fundamental rating of 3 out of 10. We evaluated PINK against 16 industry peers in the Health Care Equipment & Supplies industry. PINK scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. PINK is valued quite expensively, but it does show have an excellent growth rating.
1. Profitability
1.1 Basic Checks
In the past year PINK has reported negative net income.
In the past year PINK has reported a negative cash flow from operations.
In the past 5 years PINK always reported negative net income.
In the past 5 years PINK always reported negative operating cash flow.
1.2 Ratios
PINK has a Return On Assets (-239.48%) which is comparable to the rest of the industry.
The Return On Equity of PINK (-412.07%) is better than 62.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -239.48% | ||
| ROE | -412.07% | ||
| ROIC | N/A |
ROA(3y)-63.49%
ROA(5y)-88.85%
ROE(3y)-86.41%
ROE(5y)-118.03%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
PINK's Gross Margin of 59.01% is fine compared to the rest of the industry. PINK outperforms 68.75% of its industry peers.
PINK's Gross Margin has improved in the last couple of years.
PINK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 59.01% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.47%
GM growth 5YN/A
2. Health
2.1 Basic Checks
PINK does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PINK has more shares outstanding
Compared to 5 years ago, PINK has more shares outstanding
PINK has a worse debt/assets ratio than last year.
2.2 Solvency
PINK has an Altman-Z score of -24.17. This is a bad value and indicates that PINK is not financially healthy and even has some risk of bankruptcy.
PINK has a Altman-Z score (-24.17) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.02 indicates that PINK is not too dependend on debt financing.
PINK has a Debt to Equity ratio of 0.02. This is amongst the best in the industry. PINK outperforms 93.75% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -24.17 |
ROIC/WACCN/A
WACC8.78%
2.3 Liquidity
PINK has a Current Ratio of 1.21. This is a normal value and indicates that PINK is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of PINK (1.21) is better than 81.25% of its industry peers.
PINK has a Quick Ratio of 1.17. This is a normal value and indicates that PINK is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.17, PINK belongs to the top of the industry, outperforming 93.75% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.21 | ||
| Quick Ratio | 1.17 |
3. Growth
3.1 Past
PINK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.89%, which is quite impressive.
The Revenue has grown by 201.31% in the past year. This is a very strong growth!
PINK shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 354.72% yearly.
EPS 1Y (TTM)36.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%62.95%
Revenue 1Y (TTM)201.31%
Revenue growth 3Y354.72%
Revenue growth 5YN/A
Sales Q2Q%157.2%
3.2 Future
PINK is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.18% yearly.
PINK is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 119.88% yearly.
EPS Next Y21.56%
EPS Next 2Y18.63%
EPS Next 3Y18.41%
EPS Next 5Y19.18%
Revenue Next Year244.83%
Revenue Next 2Y205.13%
Revenue Next 3Y171.19%
Revenue Next 5Y119.88%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
PINK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PINK. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PINK's earnings are expected to grow with 18.41% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y18.63%
EPS Next 3Y18.41%
5. Dividend
5.1 Amount
No dividends for PINK!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
TSX-V:PINK (1/6/2026, 7:00:00 PM)
0.345
-0.03 (-6.76%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners22.19%
Inst Owner ChangeN/A
Ins Owners21.86%
Ins Owner ChangeN/A
Market Cap38.42M
Revenue(TTM)1.89M
Net Income(TTM)-14.35M
Analysts80
Price Target1.89 (447.83%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)25.13%
Min EPS beat(2)22.11%
Max EPS beat(2)28.15%
EPS beat(4)2
Avg EPS beat(4)-8.72%
Min EPS beat(4)-66.34%
Max EPS beat(4)28.15%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-44.66%
Min Revenue beat(2)-57.22%
Max Revenue beat(2)-32.1%
Revenue beat(4)2
Avg Revenue beat(4)18.14%
Min Revenue beat(4)-57.22%
Max Revenue beat(4)160.4%
Revenue beat(8)4
Avg Revenue beat(8)3.99%
Revenue beat(12)5
Avg Revenue beat(12)-7.2%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.73%
PT rev (3m)6.73%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.69%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-6.78%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 14.88 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 8.06 | ||
| P/tB | 8.06 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.33
EYN/A
EPS(NY)-0.2
Fwd EYN/A
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)-0.14
OCFYN/A
SpS0.02
BVpS0.04
TBVpS0.04
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -239.48% | ||
| ROE | -412.07% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 59.01% | ||
| FCFM | N/A |
ROA(3y)-63.49%
ROA(5y)-88.85%
ROE(3y)-86.41%
ROE(5y)-118.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.47%
GM growth 5YN/A
F-Score2
Asset Turnover0.31
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.21 | ||
| Quick Ratio | 1.17 | ||
| Altman-Z | -24.17 |
F-Score2
WACC8.78%
ROIC/WACCN/A
Cap/Depr(3y)208.17%
Cap/Depr(5y)571.74%
Cap/Sales(3y)624.9%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%62.95%
EPS Next Y21.56%
EPS Next 2Y18.63%
EPS Next 3Y18.41%
EPS Next 5Y19.18%
Revenue 1Y (TTM)201.31%
Revenue growth 3Y354.72%
Revenue growth 5YN/A
Sales Q2Q%157.2%
Revenue Next Year244.83%
Revenue Next 2Y205.13%
Revenue Next 3Y171.19%
Revenue Next 5Y119.88%
EBIT growth 1Y20.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year8.31%
EBIT Next 3Y15.32%
EBIT Next 5Y24.33%
FCF growth 1Y-35.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-16.75%
OCF growth 3YN/A
OCF growth 5YN/A
PERIMETER MEDICAL IMAGING AI / PINK.CA FAQ
What is the ChartMill fundamental rating of PERIMETER MEDICAL IMAGING AI (PINK.CA) stock?
ChartMill assigns a fundamental rating of 3 / 10 to PINK.CA.
Can you provide the valuation status for PERIMETER MEDICAL IMAGING AI?
ChartMill assigns a valuation rating of 0 / 10 to PERIMETER MEDICAL IMAGING AI (PINK.CA). This can be considered as Overvalued.
Can you provide the profitability details for PERIMETER MEDICAL IMAGING AI?
PERIMETER MEDICAL IMAGING AI (PINK.CA) has a profitability rating of 2 / 10.
What is the earnings growth outlook for PERIMETER MEDICAL IMAGING AI?
The Earnings per Share (EPS) of PERIMETER MEDICAL IMAGING AI (PINK.CA) is expected to grow by 21.56% in the next year.